Valion Bio (VBIO) EBITDA Margin (2021 - 2026)
Valion Bio (VBIO) posted quarterly EBITDA Margin of 91.25% for Q4 2025, up 91514.0% year-over-year from N/an in Q4 2024, and up 105.37% quarter-over-quarter from 1700.68% in Q3 2025.
Valion Bio (VBIO) EBITDA Margin (2021 - 2026) Analysis & Trends
Valion Bio's EBITDA Margin history runs 5 years deep, the most recent figure standing at 91.25% for Q4 2025.
- In Q4 2025, EBITDA Margin rose 91514.0% year-over-year to 91.25%; the TTM figure through Dec 2025 stood at 1531.41% (down 80564.0% YoY), while the FY2025 annual figure was 8.38%, up 73415.0% from the prior year.
- EBITDA Margin for Q4 2025 stood at 91.25%, up from 1700.68% in the prior quarter.
- The five-year high for EBITDA Margin was 91.25% in Q4 2025, with the low at 2248.84% in Q2 2025.
- The 5-year median for EBITDA Margin is 580.4% (2021), against an average of 819.8%.
- Peak annual rise in EBITDA Margin reached 91514 bps in 2025, while the deepest fall reached 170802 bps in 2025.
- Valion Bio's EBITDA Margin stood at 589.2% in 2021, then rose by 6 bps to 552.94% in 2022, then retreated by 14 bps to 628.57% in 2023, then plunged by 31 bps to 823.89% in 2024, then soared by 111 bps to 91.25% in 2025.
- Business Quant data shows VBIO's EBITDA Margin at 91.25% in Q4 2025, 1700.68% in Q3 2025, and 2248.84% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 | -115.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -115.38% |
| Dec 31, 2025 | 91.25% |
| Sep 30, 2025 | -1,700.68% |
| Jun 30, 2025 | -2,248.84% |
| Mar 31, 2025 | -2,151.43% |
| Dec 31, 2024 | -823.89% |
| Sep 30, 2024 | -1,135.71% |
| Jun 30, 2024 | -904.29% |
| Mar 31, 2024 | -443.41% |
| Dec 31, 2023 | -628.57% |
| Sep 30, 2023 | -624.11% |
| Jun 30, 2023 | -1,319.88% |
| Mar 31, 2023 | -562.77% |
| Dec 31, 2022 | -552.94% |
| Sep 30, 2022 | -541.72% |
| Jun 30, 2022 | -571.59% |
| Mar 31, 2022 | -523.60% |
| Dec 31, 2021 | -589.20% |
| Sep 30, 2021 | -443.68% |
| Jun 30, 2021 | -393.66% |